Activity Overview
This educational activity is an archive of the live conference held on April 11, 2026.
Target Audience
This educational activity is directed toward medical oncologists,
surgical oncologists, radiation oncologists, gastroenterologists, and
hepatologists who are interested in the treatment of GI cancers. Nurse
practitioners, physician assistants, nurses, pathologists, pharmacists, and
other health care professionals involved in the treatment and management of
patients with GI cancers are invited to attend.
Learning Objectives
- Assess the clinical utility of novel molecular and genomic strategies for personalizing treatment decisions in patients with gastrointestinal (GI) cancers
- Evaluate the clinical impact of recent findings from landmark trials of emerging treatment strategies for the management of GI cancers
Anthony El-Khoueiry, MD
Associate
Director for Clinical Research
Chief,
Section of Developmental Therapeutics/Phase I Program
Verna
R. Richter Chair in Cancer Research
USC
Norris Comprehensive Cancer Center
Los Angeles, CA
Sandra Algaze, MD
Assistant Professor of Clinical Medicine
Division of Medical Oncology -
Gastrointestinal Oncology
USC Norris Comprehensive Cancer Center
University of Southern California
Los Angeles, CA
Kristen Ciombor, MD, MSCI
Associate Professor of Medicine, Division of
Hematology and Oncology
Vanderbilt University Medical Center
Nashville, TN
Syma Iqbal, MD
Associate Professor of Clinical Medicine
Section Head, Gastrointestinal Oncology
Medical Director, Inpatient Services and
Ambulatory Services, Norris Cancer Hospital
Norris Comprehensive Cancer Center, Keck
School of Medicine
University of Southern California
Los Angeles, CA
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
